Nuclear Medicine: Page 359

PET, PET/CT help determine RFA outcomes in lung cancer treatment
By Jonathan S. Batchelor
The use of FDG-PET or PET/CT to assess the amount of tumor destruction after radiofrequency ablation (RFA) provides more valuable information than CT alone for the treatment of lung tumors, according to multicenter research presented last week at the American Roentgen Ray Society (ARRS) meeting in Vancouver, British Columbia.
May 11, 2006
Draxis posts Q1 downturn
By AuntMinnie.com staff writers
Canadian pharmaceutical developer Draxis Health reported that its fiscal 2006 first-quarter (end-March 31) revenues and earnings were below the first quarter of 2005, but were an improvement over the immediately preceding fourth quarter of 2005.
May 10, 2006
Intradermal injection for breast scintigraphy allows direct access to swollen nodes
By Shalmali Pal
A few years ago, U.K. clinicians studied the optimal method for imaging lymphatic vessels of the upper limb, and found that intradermal injection provided rapid deployment of radiotracers to the vessels, making it ideal for imaging lymphatic morphology. But does this method work as well in the case of breast cancer-related lymphedema? The same researchers sought the answer to that question with a new study in the American Journal of Roentgenology.
May 9, 2006
2006 05 09 15 08 46 706
NOPR opens, with modifications
By AuntMinnie.com staff writers
The U.S. National Oncologic PET Registry (NOPR) opened yesterday with the acceptance of its first patient entries. The registry permits participating Medicare beneficiaries to receive PET coverage for many types of cancers.
May 8, 2006
Siemens reports first Biograph 64 patient scans
By AuntMinnie.com staff writers
Siemens Medical Solutions said that the first patients have been scanned with its Biograph 64-slice PET/CT scanner.
May 7, 2006
Schering divests CIS radiopharma unit
By AuntMinnie.com staff writers
German contrast media firm Schering has completed the divestiture of the radiopharmaceutical business of CIS bio international to a consortium formed by Belgian companies Ion Beam Applications and the Institut National des Radioéléments (IRE).
May 7, 2006
PET/CT is powerful for radiation therapy planning
By Jonathan S. Batchelor
VANCOUVER - Fusion imaging provided by PET/CT may improve the accuracy of radiation therapy planning by decreasing errors caused by organ motion and deformation, according to a presentation at this week's American Roentgen Ray Society (ARRS) meeting.
May 3, 2006
Digirad Q1 revenues up, but loss grows
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad reported first-quarter revenue of $19 million, up 5.5% compared with the $18 million booked in the first quarter of 2005.
May 1, 2006
Neoprobe revenues climb in Q1
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe reported first-quarter revenues of $1.8 million, up 20% compared with the $1.5 million reported a year ago.
May 1, 2006
GE installs PET/CT in Boston
By AuntMinnie.com staff writers
GE Healthcare has shipped its first 64-slice PET/CT Discovery VCT system to Brigham & Women's Hospital in Boston.
April 27, 2006
European nuclear medicine market shows limited growth
By AuntMinnie.com staff writers
An estimated 5.4 million diagnostic nuclear medicine patient studies were performed in Western Europe in 2005, a negligible increase from 2004, according to a new study published by healthcare consultants Medical Options of London.
April 24, 2006
Eastern Isotopes changes identity
By AuntMinnie.com staff writers
Ion Beam Applications (IBA) has changed the name of its Eastern Isotopes U.S. subsidiary to IBA Molecular.
April 20, 2006
Previous Page
Page 359 of 439
Next Page